Thromboxane A2 (TXA2) Receptor Blockade Suppresses Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Stimulated Vascular Endothelial Cells

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2000 Apr 12

PMID 10759766

Citations 8

Authors

T Ishizuka

S Sawada

K Sugama

A Kurita

Affiliations

Soon will be listed here.

Abstract

In a previous study, it was reported that stimulation with a TXA2 receptor agonist, U46619, augments the expression of adhesion molecules by human umbilical vein endothelial cells (HUVEC). In the present study we showed that U46619 augments the expression of MCP-1 in HUVEC, both at the protein and mRNA levels. Pretreatment with TXA2 receptor antagonists greatly diminishes the extent of tumour necrosis factor-alpha (TNF-alpha)-, platelet-activating factor (PAF)-, or U46619-induced mRNA accumulation and production of MCP-1. Protein kinase C (PKC) inhibitors diminish U46619-induced mRNA accumulation and production of MCP-1. NAC, which inhibits nuclear factor kappaB (NF-kappaB) activation and activating protein 1 (AP-1) binding activity, inhibits the expression of MCP-1 at the protein and mRNA levels. These results indicate that in HUVEC stimulation via the TXA2 receptors augments MCP-1 production by induction of the NF-kappaB and AP-1 binding activity through the PKC system.

Citing Articles

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.

Chiang K, Rizk J, Nelson D, Krishnamurti L, Subbian S, Imig J Expert Opin Ther Targets. 2022; 26(1):13-28.

PMID: 35068281 PMC: 10119876. DOI: 10.1080/14728222.2022.2031975.

Thromboxane A receptor antagonist (ONO-8809) attenuates renal disorders caused by salt overload in stroke-prone spontaneously hypertensive rats.

Nagatani Y, Higashino T, Kinoshita K, Higashino H Clin Exp Pharmacol Physiol. 2021; 48(10):1391-1401.

PMID: 34152603 PMC: 8518871. DOI: 10.1111/1440-1681.13543.

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2.

Lucotti S, Cerutti C, Soyer M, Gil-Bernabe A, Gomes A, Allen P J Clin Invest. 2019; 129(5):1845-1862.

PMID: 30907747 PMC: 6486338. DOI: 10.1172/JCI121985.

Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player.

Bode M, Mackman N Vascul Pharmacol. 2014; 62(2):57-62.

PMID: 24858575 PMC: 4116464. DOI: 10.1016/j.vph.2014.05.005.

Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.

Li X, Tai H PLoS One. 2013; 8(1):e54073.

PMID: 23349788 PMC: 3547941. DOI: 10.1371/journal.pone.0054073.

References

Howard O, Ben-Baruch A, Oppenheim J . Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends Biotechnol. 1996; 14(2):46-51. DOI: 10.1016/0167-7799(96)80920-6. View

Cai J, Hudson S, Ye M, Chin Y . The intracellular signaling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium. Cell Immunol. 1996; 167(2):269-75. DOI: 10.1006/cimm.1996.0035. View

Ishizuka T, Suzuki K, Kawakami M, Hidaka T, Matsuki Y, Nakamura H . Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells. Eur J Pharmacol. 1996; 312(3):367-77. DOI: 10.1016/0014-2999(96)00478-5. View

Martin T, Cardarelli P, Parry G, Felts K, Cobb R . Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol. 1997; 27(5):1091-7. DOI: 10.1002/eji.1830270508. View

Weber C, Lu C, Casasnovas J, Springer T . Role of alpha L beta 2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J Immunol. 1997; 159(8):3968-75. View

Wempe F, Lindner V, Augustin H . Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol. 1997; 17(11):2471-8. DOI: 10.1161/01.atv.17.11.2471. View

Ishizuka T, Kawakami M, Hidaka T, Matsuki Y, Takamizawa M, Suzuki K . Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol. 1998; 112(3):464-70. PMC: 1905002. DOI: 10.1046/j.1365-2249.1998.00614.x. View

Villard E, Alonso A, Agrapart M, Challah M, Soubrier F . Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial cells. J Biol Chem. 1998; 273(39):25191-7. DOI: 10.1074/jbc.273.39.25191. View

Daniel T, Liu H, Morrow J, Crews B, Marnett L . Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999; 59(18):4574-7. View

10.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

11.

Spagnuolo P, Ellner J, Hassid A, Dunn M . Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest. 1980; 66(3):406-14. PMC: 371667. DOI: 10.1172/JCI109870. View

12.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

13.

Ceuppens J, Vertessen S, Deckmyn H, Vermylen J . Effects of thromboxane A2 on lymphocyte proliferation. Cell Immunol. 1985; 90(2):458-63. DOI: 10.1016/0008-8749(85)90210-2. View

14.

Valente A, Graves D, Vialle-Valentin C, Delgado R, Schwartz C . Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 1988; 27(11):4162-8. DOI: 10.1021/bi00411a039. View

15.

Shirakawa F, Mizel S . In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol. 1989; 9(6):2424-30. PMC: 362315. DOI: 10.1128/mcb.9.6.2424-2430.1989. View

16.

Rosentreter U, Boshagen H, Seuter F, Perzborn E, Fiedler V . Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer. Arzneimittelforschung. 1989; 39(12):1519-21. View

17.

Sica A, Wang J, Colotta F, Dejana E, Mantovani A, Oppenheim J . Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol. 1990; 144(8):3034-8. View

18.

Ghosh S, Baltimore D . Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990; 344(6267):678-82. DOI: 10.1038/344678a0. View

19.

Roederer M, Staal F, Raju P, Ela S, Herzenberg L . Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A. 1990; 87(12):4884-8. PMC: 54223. DOI: 10.1073/pnas.87.12.4884. View

20.

Ritchie A, Johnson D, Ewenstein B, Pober J . Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine. J Immunol. 1991; 146(9):3056-62. View